Environmental exposure, and other behavioral risk factors in breast cancer

Current Cancer Therapy Reviews

Volumn 2, Issue 1, 2006, Pages 3-21

  Kruk, Joanna ^a   Aboul Enein, Hassan Y ^b  

^a UNIVERSITY OF SZCZECIN   (Poland)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Breast cancer; Environment; Epidemiology; Estrogen metabolism; Life style

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; AROMATIC AMINE; CARCINOGEN; CHEMICAL COMPOUND; CHLORDANE; CHLORPHENOTANE; DIELDRIN; ESTRADIOL; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; ORGANOCHLORINE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ALCOHOL CONSUMPTION; BREAST CANCER; BREAST CARCINOGENESIS; CANCER MORTALITY; CANCER RISK; CLINICAL TRIAL; DIETARY INTAKE; DRUG MEGADOSE; ELECTROMAGNETIC FIELD; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ESTROGEN METABOLISM; EUROPE; FEMALE GENITAL SYSTEM; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PUBLIC HEALTH; RADIATION EXPOSURE; REVIEW; RISK FACTOR; SITTING; SMOKING; WESTERN HEMISPHERE;

EID: 33746134797     PISSN: 15733947     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339406775471795     Document Type: Review

References (280)

1. Mettlin G. Global breast cancer mortality statistics. CA Cancer J Clin 1999; 49: 138-144.
2. Kelsey J, Gammon MG. The epidemiology of breast cancer. CA-A. Cancer J Clinicians 1991, 41: 146-165.
3. McPherson K, Steel CM, Dixon JM. Breast cancer epidemiology, risk factors, and genetics. Br J Med 1994; 309: 1003-1006.
4. Stasiolek D, Kwasniewska M, Drygas W. Rak sutka - wybrane czynniki ryzyka, prewencja pierwotna. Przeglad Lekarski 2002; 59: 26-30.
5. Madigan MP, Zielger RG, Benichou J, et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995; 87: 1681-1685.
6. Hrudey SE, Krewski D. Is there a safe level of exposure to a carcinogen. Environ Sci Technol 1995; 29: 370A-375A.
7. Wolff MS, Toniolo PG. Environmental organochlorine exposure as a potential etiologic factor in breast cancer. Environ. Health Perspect. 1995; 103 (Suppl.7): 141-145.
8. Wolff MS, Weston A. Breast cancer risk and environmental exposures. Environ. Health Perspect. 1997; 105 (Suppl. 4): 891-896.
9. Gammon MD. Ester MJ. Britton, JA. Recreational and occupational physical activities and risk of breast cancer. J Natl Cancer Inst 1998; 90: 100-117.
10. Lattika P, Pukkala E, Vihko V. Relationship between the risk of breast cancer and physical activity. An epidemiological perspective. Sports Med 1998; 16: 133-143.
11. Thune I, Furberg AS. Physical activity and cancer risk: dose-response and cancer, all sites and site-specific. Med Sci Sports Exerc 2001; 33 (Suppl.6): S530-S550.
12. Kruk J. Physical activity and risk of breast cancer. Biol Sport 2002; 19: 3-32.
13. Dorn J, Vena J, Brasure J, et al. Lifetime physical activity and breast cancer risk in pre-and postmenopausal women. Med Sci Sports Exerc 2003; 35: 278-285.
14. Yang D, Bernstein L, Wu AH. Physical activity and breast cancer risk among Asian-American Women in Los Angeles. Cancer 2003; 97: 2565-2575.
15. Malone KE, Daling JR, Weiss NS. Oral contraceptives in relation to breast cancer. Epidemiol Rev 1993; 15: 80-97.
16. Willett WC. What should we eat? Science 1994; 264: 532-537.
17. Willett WC Diet, nutrition and avoidable cancer. Environ Health Perspect 1995; 103 (Suppl 8):165-170.
18. Wright RM, McManaman JL, Repine JE. Alcohol - induced breast cancer: a proposed mechanism. Free Radic Biol Med 1999; 26: 348-354.
19. Alberg AJ, Singh S, May JW, et al. Epidemiology, prevention, and early detection of breast cancer. Curr Opin Oncol 2000; 12: 515-520.
20. McTiernan A. Association between energy balance and body mass index and risk of breast carcinoma in women from diverse racial and ethnic backgrounds in the U.S. Cancer 2000; 88 (suppl.5): 1248-1255.
21. Key JT, Allen NE, Spencer EA, et al. The effect of diet on risk of cancer. Lancet 2002; 360: 861-868.
22. Kushi L, Giovannucci E. Dietary fat and cancer. Am J Med 2002; 113: 63S-70S.
23. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analysis of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
24. Key TJ, Verkasalo PK, Banks E. Epidemiology and breast cancer. Lancet Oncol 2001; 2: 133-140.
25. Snedeker SM Pesticides and breast cancer risk: a review of DDT, DDE, and Dieldrin. Environ. Health. Perspect. 2001; 109 (suppl. 1): 35-47.
26. Hüskes R, Levsen K. Pesticides in rain. Chemosphere 1997; 35: 3013-3024.
27. Dubus IG, Hollis JM, Brown CD. Pesticides in rainfall in Europe. Environ Pollut 2000; 110: 331-344.
28. Hamers T, Smit MD, Murk AJ, et al. Biological and chemical analysis of the toxic potency of pesticides in rainwater. Chemosphere 2001; 45: 609-624.
29. Hamers T, van den Brink PJ, Mos L, et al. Estrogenic and esterase-inhibiting potency in rainwater in relation to pesticide concentrations, sampling season and location. Environ. Pollution 2003; 123: 47-65.
30. Mucci LA, Sandin S, Balter K, et al. Acrylamide intake and breast cancer risk in Swedish women. JAMA 2005; 293: 1326-1327.
31. Travis CC, Hester ST. Mercury is found in fish in remote lakes; lead is found in Greenland snow; and PCBs, dioxin, and pesticides are found in the Arctic. Environ Sci Technol 1991; 25: 815-819.
32. Hargrave BT, Harding GC, Vass WP, et al. Organochlorine pesticides and polychlorinated biphenyls in the Arctic ocean food veb. Arch Environ Contam Toxicol 1992; 22: 41-54.
33. Zabik ME, Booren A, Zabik MJ, et al. Pesticide residues, PCBs and PAH in baked, charbroiled, salt boiled and smoked Great Lakes lake trout. Food Chemistry 1996; 55: 231-239.
34. Ahmad N, Bugueno G, Guo L, et al. Determination of organochlorine, and organophosphate pesticide residues in fruits, vegetables and sediments. J Environ Sci Health 1999; 34: 829-848.
35. Wolff MS. Occupationally derived chemicals in breast cancer milk. Am J Ind Med 1983; 4: 259-281.
36. Mussalo-Rauhamaa H, Pyysalo H, Antervo K. Relation between the content of organochlorine compounds in Finnish human milk and characteristics of the mothers. J Toxicol Environ Health 1988; 25: 1-29.
37. Robinson PE, Mack GA, Remmers J, et al. Trends of PCB, hexachlorobenzene, and β-benzene hexachloride levels in the adipose tissue of the US population. Environ Res 1990; 53: 175-192.
38. Jensen AA. Transfer of chemical contaminants into human milk. In: Chemical Contaminants in Human Milk (A.A.Jensen and S.A.Slorach, eds.), Boca Raton, FL, CRC Press Inc. pp. 9-19; 1991
39. Chikuni O, Skate JU, Nyazema N, et al. Residues of organochlorine pesticides in human milk from mother living in the greater Harare area of Zimbabwe. Cent Afr J Med 1991; 37: 136-140.
40. Sim MR, McNeil JJ. Monitoring chemical exposure using breast milk: a methodological review. Am J Epidemiol 1992; 136: 1-11.
41. Byczkowski JZ, Gearhart JM, Fisher JW. Occupational exposure of inflants to toxic chemicals in breast milk. Nutrition 1994; 10: 143-148.
42. Waliszewsk, SM, Pardio VTS, Chantiri J.N.P, et al. Organochlorine residues in adipose tissue of Mexicans. Sci Total Environ 1996; 181: 125-131.
43. Lopez-Carrillo L, Blair A, Lopez-Cervantes M, et al. Dichlorodiphenyltrichloroethane serum levels in breast cancer risk. a case-control study from Mexico. Cancer Res 1997; 57: 3728-3732.
44. Fisher J, Mahle D, Bankston L, et al. Lactational transfer of volatile chemicals in breast milk. AIHA Journal 1997; 58: 425-431.
45. Norén K, Meironyté D. Contaminants in Swedish human milk. Decreasing levels of organochlorine and increasing levels of organobromine compounds. Organohalogen Comp 1998; 38: 1-4.
46. Aronson K, Biller A, Woolcott C, et al. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol. Biomarkers Prev 2000; 9: 55-63.
47. Norén K, Meironyté D. Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years. Chemosphere 2000; 40: 1111-1123.
48. Ward ME, Schulte P, Grejewski B, et al. Serum organochlorine levels and breast cancer: A nested case-control study of Norwegian women. Cancer Epiderniol Biomark Prevention 2000; 9: 1357-1367.
49. Calle EE, Frumkin H, Henley SJ, et al. Organochlorines and breast cancer risk. CA Cancer J Clin 2002; 52: 301-309.
50. de Wit CA An overview of brominated flame retardants in the environment. Chemosphere 2002; 46: 583-624.
51. Manz A, Berger J, Dwyer JH, et al. Cancer mortality among workers in a chemical plant contaminated with dioxin. Lancet 1991; 338: 959-964.
52. Schrter-Kermani C, Helm D, Herrmann T, et al. The German enviromental specimen bank-application in trend monitoring of polybrominated diphenyl ethers in human blood. Organohalogen Compounds 2000; 7: 49-52.
53. Soto AM, Chung KL, Sonnenschein C. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 1994; 102: 380-383.
54. Kirshman V, Safe S. Polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans as antiestrogens in MCF-7 human breast cancer cells: quantitative structure - activity relationships. Toxicol Appl Pharmacol 1993; 120: 55-61.
55. Holcomb H, Safe S. Inhibition of 7,12-DMBA-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzodioxin. Cancer Lett 1994; 82: 43-47.
56. Guillete LJ, Gross TS, Masson GR, et al. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 1994; 102: 680-688.
57. Bergon JM, Crews D, McLachlan JA. PCBs as environmental estrogens: turtle sex determination as a biomarker of environmental contemination. Environ. Health Perspect 1994; 102: 780-781.
58. Pollack N, Cunningham AR, Rosenkranz HS. Environmental persistence of chemicals and their carcinogenic risks to humans. Mutat Res 2003; 528: 81-91.
59. Arnold SF, Klotz DM, Collins BM, et al. Synergic activation of estrogen receptor with combinations of environmental chemicals. Science 1996; 272: 1489-1492.
60. Vasserman M, Nogueira DP, Tamtis L, et al. Organochlorine compounds in neoplastic; and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 1976; 15: 478-484.
61. Falck E Jr, Ricci A Jr, Wolff MS, el al. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 1992; 47: 143-146.
62. Dewailly E, Dodin S, Verreault R, el al. High organochlorine body burden in women with estrogen receptor positive breast cancer. J Natl Cancer Inst 1994; 86: 232-234.
63. Olaya-Contreras P, Rodiguez-Villamil J, Posso-Valencia HJ, et al. Organochlorine exposure and breast cancer risk in Colombian women. Cadernos de Saude Publica 1998; 14 (Suppl.3) 125-132.
64. Hφoyer AP, Grandjean P, Jφorgevsen T, et al. Organochlorine exposure and risk of breast cancer. Lancet 1998; 352: 1816-1820.
65. Hφoyer AP, Jorgensen T, Grandjean P, et al. Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control 2000a 11: 177-184.
66. Hφoyer AP, Jφorgevsen T, Brock JW, et al. Organochlorine exposure and breast cancer survival. J Clin Epidem 2000; 53: 323-330.
67. Romieu I, Hernandez-Avila M, Lazcano-Ponce, E, et al. Breast cancer, lactation history nad serum organochlorines. Am J Epidemiol 2000; 152: 363-370.
68. Charlier C, Albert A, Herman P, et al. Breast cancer and serum organochlorine residues. Occup Environ Med 2003; 60: 348-351.
69. Helzlsouer KJ, Alberg AJ, Huang HY, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomark Prev 1999; 8: 525-532.
70. Zheng T, Holford M Mayne ST, et al. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomark Prev 2000; 9:167-174.
71. Wolff MS, Toniolo P, Lee E, et al. Blood levels of organochlorine residue and risk of breast cancer. J Natl Cancer Inst 1993; 85: 648-652.
72. Dorgan JF, Brock JW, Rothman W, et al. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 1999; 10: 1-11.
73. Demers A, Ayotte P, Brisson J, et al. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomark Prev 2000; 9: 161-166.
74. Stellman SD, Djordjevic MV, Britton JA, et al. Breast cancer risk in relation to adiptose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomark Prev 2000; 9: 1241-1249.
75. Wolff MS, Zeleniuch-Jacquotte A, Dubin N, et al. P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomark Prev 2000; 9: 271-277.
76. Demers A, Ayotte P, Brisson J, et al. Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener specific analysis. Am J Epidemiol 2002; 155: 629-635.
77. Gammon MD, Wolff MS, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomark Prev 2002; 11: 686-697.
78. Krieger N, Wolff MS, Hiatt RA, et al. Breast cancer and serum organochlorines. A perspective study among White, Black, and Asian women. J Natl Cancer Inst 1994; 86: 589-599.
79. Gold LS, Slone TH, Manley NB, et al. The Carcinogenic Potency Database: analysis of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute / National Toxicology Program. Environ Health Perspect 1991; 96: 11-15.
80. DeBruin LS, Josephy PD, Pawliszyn JB. Detection of monocyclic aromatic amines, possible mammary carcinogens, in human milk. Chem Res Toxicol 1999; 12: 78-92.
81. Bulbulyan MA, Figgs LW, Zahm SH, et al. Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Mosow. Int J Epidemiol 1995; 24: 266-275.
82. Zheng W, Campbell D, Sinha R, et al. Well-done meat consumption and the risk of breast cancer. J Nat Cancer Instit 1998; 1724-1729.
83. Li D, Walcott FL, Chang P, et al. Genetic and envirornmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer. Cancer Res 2002; 62: 4566-4570.
84. Gorlewska-Roberts K, Green B, Fares M, et al. Carcinogen-DNA adducts in human breast epithiol cells. Environ Mol Mutagen 2002; 39: 184-192.
85. Aschengrau A, Rogers S, Ozonoff D. Perchloroethylene-contaminated drinking water and the risk of breast cancer: additional results from Cape Cod, Massachusetts, USA. Environ Health Perspect 2003; 111: 167-173.
86. Katz RM, Jowett D. Female laundry and dry cleaning workers in Wisconsin: a mortality analysis. Am J Public Health 1981; 71: 305-307.
87. Duh RW, Asal NR. Mortality among laundry and dry cleaning workers in Oklahoma. Am J Public Health 1984; 74: 1278-1280.
88. Walker JT, Burnett CA, Lalich NR, et al. Cancer mortality among laundry and dry cleaning workers. Am J Ind Med 1997; 32: 614-619.
89. Ruder AM, Ward EM, Brown DP. Mortality in dry-cleaning workers; an update. Am J Ind Med 2001; 39: 121-132.
90. Band PR, Le ND, Fang R, et al. Identification of occupational cancer risk in British Columbia: A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med 2000; 42: 284-310.
91. (a) Band P, Nhu DL, Deschamps M, et al. Identification of occupational cancer risk in British Columbia. JOEM 2000; 42:284-310;
92. (b) Hansen J. Breast cancer among relatively young women employed in solvent-using industries. Am J Ind Med 1999; 36: 43-47.
93. Peposka B, Szeszenia-Dbrowska B. Occupational risk factors for breast cancer in epidemiological studies. Medycyna Pracy 2001; 52: 483-495. (in Polish)
94. Gunnarsdottir HK, Aspelund T, Karlsson T, et al. Occupational risk factors for breast cancer among nurses. Int J Occup Environ Health 1997; 3: 254-258.
95. Petralia SA, Dosemeci M, Adams EE, et al. Cancer mortality among women employed in health care occupations in 24 U.S. states, 1984-93. Am J Ind Med 1999; 36: 159-165.
96. Colburn T, von Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wild life and human. Environ Health Perspect 1993; 101: 378-384.
97. McKinney JD, Waller CL. Polychlorinated biphenyls as hormonally active structural analogues. Environ Health Perspect 1994; 102: 290-297.
98. John EM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev 1993; 15: 157-162.
99. Tokunaga M, Land CE, Tokuoka S, et al. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 1994; 138: 209-223.
100. Land CE. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. JAMA 1995; 274: 402-407.
101. Hrubec Z, Boice JD Jr, Monson RR, et al. Breast cancer after multiple chest fluoroscopies: Second follow-up of Massachussetts women with tuberculosis. Cancer Res 1989; 49: 229-234.
102. Miller AB, Howe GR, Sherman GJ. Mortality from breast cancer after irradiation during fluoroscopic examination in patients being treated for tuberculosis. New England J Med 1989; 321: 1285-1288.
103. Abrahamsen en JF, Andersen A, Hannisdal E. Second malignancies after treatment of Hodgkin 'a disease - the influence of treatment, follow-up time, and age. J Clin Oncology 1993; 11: 255-259.
104. Sankaranarayanan K, Chakraborty R. Cancer predisposition, radiosensitivity and the risk of radiation - induced cancers. I Background Radiat Res 1995; 143: 121-143.
105. Montesano R, Hall J. Envirommental causes of human cancers. Eur J Cancer 2001; 37: 567-587.
106. Land CE, Boice JD Jr., Shore RE, et al. Breast cancer risk from low dose exposures to ionising radiation: results of parallel analysis of three exposed populations of women. J Natl Cancer Inst 1980; 65: 353-376.
107. Jia WH, Wang JX Li BX, et al. A nested case-control study on female breast cancer risk among medical diagnostic X-ray workers in China. China J Radiol Med Prot 1998; 18: 73-75.
108. Wang M Zhang LA, Li BX, et al. Cancer incidence and risk estimation among medical X-ray workers in China, 1950-1995. Health Phys 2002; 82: 455-466.
109. Van Wijngraarden E, Nylander-French LA, Millikan RC, et al. Population-based case-control study of occupational exposure to electromagnetic fields and breast cancer. Ann Epidemiol 2001; 11: 297-303.
110. Doody MM, Mandel JS, Lubin JH, et al. Mortality among United States radiologic technologists, 1926-90. Cancer Causes Control 1998; 9: 67-76.
111. Doody MM, Mandel JS, Linet MS, et al. Mortality among catholic nuns certified as radiologic technologist. Am J Ind Med 2000; 37: 339-348.
112. Morton WE. Major difference in breast cancer risk among occupations. JOEM 1995; 37: 328-335.
113. Evans JS, Wennberg JE, McNeil BJ. The influence of diagnostic radiography on the incidence of breast cancer and leukemia. N Eng J Med 1986; 315: 810-815.
114. Elcsh PL, Owens KN, King MC. Insights into the functions of BRCA1 and BRCA2. Trends Genet 2000; 16: 69-74.
115. Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors. Maturitas 2001; 38: 103-116.
116. Oliver M, Hainaut P. Tp53 mutation patters in breast cancer: searching for clues of environmental carcinogens. Cancer Biol 2001; 11: 353-360.
117. Furberg H, Millikan RC, Geradts J, et al. Environmental factors in relation to breast cancer characterized by p53 protein expression Cancer Epidemiol Biomark Prev 2002; 11: 829-835.
118. Hartmann A, Blaszyk H, Kovach JS, et al. The molecular epidemiology of p53 gene mutitions in human breast cancer. Trends Genet 1997; 13: 27-33.
119. Tynes T, Andersen A. Electromagnetic field exposure and male breast cancer. Lancet 1990; 336: 1596.
120. Matanowski GM, Breysse PN, Elliott EA. Electromagnetic field exposure and male breast cancer. Lancet 1991; 337: 737.
121. Floderus B, Tornquist S, Stenlud C. Incidence of selected cancers in Swedish railway workers, 1961-1979. Cancer Causes Control 1994; 5: 189-194.
122. Demers PA, Thomas DB, Rosenblatt KA, et al. Occupational exposure to electromagnetic fields and breast cancer in man. Am J Epidemiol 1991; 134: 340-347.
123. Loomis DP, Savitz DA, Ananth C. Breast cancer mortality among female electrical workers in the United States. J Natl Cancer Inst 1994; 86: 921-925.
124. Tynes T, Hannevik M, Andersen A, et al. Incidence of breast cancer in Norvegian female radio and telegraph operators. Cancer Causes Control 1996; 7: 197-204.
125. Johansen C, Olsen JH. Risk of cancer among Danish electric utility workers - a nationwide cohort study. Am J Epidemiol 1998; 147: 548-555.
126. Forssén UM, Feychting M, Rutquist LE, et al. Occupational and residential magnetic field exposure and breast cancer in females. Epidemiol 2000; 11: 24-29.
127. Caplan LS, Schoenfeld ER, O'Leary ES, et al. Breast cancer and electromagnetic fields - a review. Ann Epidemiol 2000; 10: 31-44.
128. Coogan PF, Aschengrau A. Exposure to power frequency magnetic fields and risk of breast cancer in the upper Cape Cod cancer incidence study. Arch Environ Health 1998; 53: 359-367.
129. Schoenfeld ER, O'Leary ES, Henderson K, et al. for the EBCLIS Group. Electromagnetic fields and breast cancer on Long Island. a case - control study. Am J Epidemiol 2003; 158: 47-58.
130. Cantor KP, Dosemeci M, Brinton LA, et al. Breast cancer mortality among female electrical workers in the United States. J Natl Cancer Inst 1995; 873: 227-228.
131. Kelsh MA, Sahl JD. Mortality among a cohort of electric utility workers, 1960-91. Am J Ind Med 1997; 31: 534-544.
132. Dees C, Garrett S, Henley D, et al. Effect of 60 Hz fields, estradiol and xenoestrogens on human breast cancer cells. Radiat Res 1996; 146: 444-456.
133. Dosemeci M, Blair A. Occupational cancer mortality among women employed in the telephone industry. J Occup Med 1994; 36: 1204-1209.
134. Coogan PF, Clapp RW, Newcomb PA, el al. Occupational exposure to 60-hertz magnetic field and risk of breast cancer in women. Epidemiol 1996; 7: 459-464.
135. Pollan K Gustavsson P. High-risk occupations for breast cancer in the Swedish female working population. Am J Public Health 1999; 89: 875-881.
136. Fear NT, Roman E, Carpenter LM, et al. Cancer in electrical workers: An analysis of cancer registrations in England, 1981-87. Br J Cancer 1996; 73: 935-939.
137. Vena JE, Freudenheim JL, Marshall JR, et al. Risk of premenopausal breast cancer and use of electric blankets. Am J Epidemiol 1994; 140: 974-979.
138. Houghton DL, Ritter L. Organochlorine residues and risk of breast cancer. J Am Coll Toxicol 1995; 14: 71-89.
139. Stevens RG Re: Risk of premenopausal breast cancer and use of electric blankets. Am J Epidemiol 1995; 142: 446.
140. Brainard GC, Kavet R, Kheifets LI. The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: A review of relevant literature. J Pineal Res 1999; 26: 65-100.
141. Ahlbom A, Cardis E, Green A, et al. Review of the epidemiologic literature on EMF and health. Environ Health Perspect 2001; 109 (suppl. 6): 911-933.
142. Erren TC. A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics. 2001; 5(Suppl): S105-S119.
143. Slesin L. (ed). Female breast cancer linked to EMFs for the third time. Associations still viewed cautiously. Microwave News 1996; 16: 5-6.
144. Davis S, Mirick DK, Stevans RG. Residential magnetic fields and the risk of breast cancer. Am J Epidemiol 2002; 155: 446-454.
145. Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987; 125: 556-561.
146. Stevens RG, Davis S, Thomas DB, et al. Electric power, pineal function, and the risk of breast cancer. FASED 11992; 6: 853-860.
147. Molis TM, Spriggs LL, Jupiter Y, et al. Melatonin modulation of estrogen-regulated protein, growth factors, and protooncogenes in human breast cancer. J Pineal Res 1995; 18: 93-103.
148. Kato M, Honma K, Shigemisu. T, et al. Effects of exposure to curcularized 50 Hz magnetic field on plasma and pineal melatonin levels in rats. Bioelectromagnetics 1993; 15: 489-492.
149. Löscher W, Wahnschoffe V, Mevissen M, et al. Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats. Oncology 1994; 51: 288-295.
150. Schernhammer ES, Hankison SE. Urinary melatonin levels and breast cancer risk J Nat Cancer Instit 2005; 97: 1084-1087.
151. Schiffman IS, Lasch HM, Rollag MD, et al. Effect of magnetic resonance imagin on the normal human pineal body: Measurement of plasma melatonin levels. J Magn Reson Imagin 1994; 4: 7-11.
152. Graham C, Cook MR, Riffle DW, et al. Nocturnal melatonin levels in human volunteers exposed to 60 Hz magnetic fields. Bioelectromagactics 1996; 17: 263-273.
153. Graham C, Cook MR, Riffle DW. Human melatonin during continuous magnetic field exposure. Bioelectromagnetics 1997; 18: 166-171.
154. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993; 15: 48-65.
155. Feigelson HS, Henderson BE. Estrogen and breast cancer. Carcinogenesis 1996; 17: 2279-2284.
156. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995; 87: 190-197.
157. Key TJA, Pike MC. The role of estrogens and progestogens in the epidemiology and prevention breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29-43.
158. Pike MC, Spicer DV, Dahmoush L, et al. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17-35.
159. Liehr JG. Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ Health Perspect 1997; 105(Suppl 3): 565-569.
160. Dao TL. The role of ovarian steroid hormones in mammary carcinogenesis. In: Pike MC, Siitery PK, Welsch CW. (Eds.), Hormones and breast cancer. Cold Spring Harbor, N.Y. Cold Spring Harbor Laboratory, pp. 281-295; 1981
161. Liehr JG. Genotoxic effects of estrogens. Mutat Res 1990; 238: 269-276.
162. Liehr JG, Roy D. Free radical generation by redox cycling of estrogens. Free Radic Biol Med 1990; 8: 415-423.
163. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1997; 36: 203-232.
164. Liehr JG, Ricci MJ. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 1996; 93: 3294-3296.
165. Davis DL, Telang NT, Osborne MP, et al. Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancer. Environ Health Perspect 1997; 105(Suppl 3): 571-576.
166. Peret FP, Estabrook A, Hewer A, et al. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol. Biomarkers Prev 1995; 4: 233-238.
167. Li D, Wang M, Dhingra K, et al. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 1996; 56: 287-293.
168. Li Y, Trush MA, Yager JD. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol. of estradiol. Carcinogenesis 1994; 15: 1421-1427.
169. Yoshie Y, Ohshima H. Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. Free Radic Biol Med 1998; 24: 341-348.
170. Kruk I. Environmental Toxicology and Chemistry of Oxygen Species. 2.1. The Handbook of Environmental Chemistry. Hutzinger, O. (ed). Springer-Verlag Berlin Heidelberg New York pp. 89-134; 1998.
171. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994; 54: 1890s- 1894s.
172. Toyokuni S, Okamoto K, Yodoi J, et al. Persistent oxidative stress in cancer. FEBS Lett 1995; 358:1-3.
173. Toyokuni S. Oxidative stress and cancer: the role of redox regulation. Biotheraphy 1998; 11: 147-154.
174. Malins DC, Holmes EH, Polissar NL, et al. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis withh potential for evaluating incidence risk. Cancer 1993; 71: 3036-3043.
175. Han X, Liehr JG. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogeriesis 1995; 16: 2571-2574.
176. Thorgeirsson SS. Endogenous DNA damage and breast cancer. Cancer 1993; 71: 2897-2899.
177. Wyllie S, Liehr JG. Role of iron in free radical generation by redox cycling of estrogen quinones: a possible mechanism of estrogen - induced tumorigenesis. Proc Am Assoc Cancer Res 1995; 36: 166.
178. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuperin (hemocuprein). J Biol Chem 1969; 224: 6049-6055.
179. Huang X, Dai J, Fournier J, et al. Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells. Free Radic Biol Med 2002; 32: 84-92.
180. Goldstein S, Meyerstein D, Czapski G. The Fenton reagents. Free Radic Biol Med 1993; 15: 435-445.
181. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995; 18: 321-336.
182. Matés JK Sanchez-Jiménez FM. Role of reactive oxygen species in apoptosis: implication for cancer therapy. Int J Biochem Cell Biol 2000; 32: 157-170.
183. Liehr JG, Jones JS. Role of iron in estrogen - induced cancer. Curr Med Chem 2001; 8: 839-849.
184. Termini J. Hydroperoxide - induced DNA damage and mutations. J Mut Res 2000; 450: 107-124.
185. Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochern J 1984; 219: 1-14.
186. Dreher D, Jound AF. Role of oxygen free radicals in cancer development Eur J Cancer 1996; 32A: 30-38.
187. Hunt CR, Sim JE, Sullivan SJ, et al. Genomic instability and catalase gene amplication induced by chronic exposure to oxidative stress. Cancer Res 1998; 58: 3986-3992.
188. Aruoma OI. Characterization of drugs as antioxidant prophylactics. Free Radic Biol Med 1996; 20: 675-705.
189. Thomsen LL, Miles DW, Happerfield L. et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995; 72: 41-44.
190. Parshad R, Price FM, Bohr VA, et al. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 1996; 74: 1-5.
191. Russo J, Gusterson BA, Rogers AE, et al. Biology of disease. Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990; 62: 244-278.
192. Friedenreich CM,Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Natur 2002; 132: 3456S-3464S.
193. McTiernan A. Behavioral risk factors in breast cancer can risk be modified? The Oncologist 2003; 8: 326-334.
194. Buell P. Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 1973; 51: 1479-1483.
195. Kamath SIC, Murill G, Chatterton RT Jr, et al. Breast cancer risk factors in two distinct Ethnic groups: Indian and Pakistani vs. American premenopausal women. Nutr Cancer 1999; 35: 16-26.
196. Wing RP. Obesity. In: Blechman, EA; Brownell, KD; eds Behavioral medicine and women: a comprehensive handbook. New York: Guilford 391-401; 1998
197. Hardman AE. Physical activity and cancer risk. Proceedings of the Nutrition Society 2001; 60: 107-113.
198. Lee IM. Physical activity and cancer prevention - data from epidemiologic studies. Med Sci Sports Exerc 2003; 35: 182-1827.
199. Frisch RE, Wyshak G, Albright NL, el al. Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br J Cancer 1985; 52: 885-891.
200. Marrett LD, Theis B, Ashbury FD, et al. Workshop Report.: Physical activity and cancer prevention. Chronic Diseases in Canada 2000; 21: 3-11.
201. Rintala PE, Pukkala E, Paakkulainen HT, et al. Self-experienced physical workload and risk of breast cancer. Scand, J Work Environ Health 2002; 28: 158-162.
202. Kruk J. Sport activity and the risk of breast cancer: results from a case-control study. Biol Sport 2003; 20: 243-259.
203. Kruk J, Aboul-Enein HY. Occupational physical activity and the risk of breast cancer. Cancer Detection and Prevention 2003; 27: 187-192.
204. McTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women. The Women's Health Initiative Cohort Study. JAMA 2003; 290: 1331-1336.
205. Patel AV, Calle EE, Bernstein L, Wu AH, et al. Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women. Cancer Causes and Control 2003; 14: 519-529.
206. Patel AV, Press MF, Kathleen M, et al. Lifetime recreational exercise activity and risk of breast carcinoma in situ. Cancer 2003b; 98: 2161-2169.
207. Rintala P, Pukkala E, Läärä E, et al. V. Physical activity and breast cancer risk among female physical education and language teachers: a 34-year follow-up. Int J Cancer 2003; 107: 268-270.
208. Luoto R, Lattikka P, Pukkala E, et al. The effect of physical activity on breast cancer risk. a cohort study of 30,548 women. Eur J Epidemiol 2000; 16: 973-980.
209. Moore DB, Folsom AR, Mink PJ, et al. Physical activity and incidence of postmenopausal breast cancer. Epidemiology 2000; 11: 292-296.
210. Lee IM, Cook NR, Rexrode KM, et al. Lifetime physical activity and risk of breast cancer. Br J Cancer 2001; 85: 962-965.
211. Hofvind SS, Thorsen SO. Physical activity and breast cancer. Tidsskr Nor Laegeforen 2001; 121: 1892-1895. (summary)
212. Ainsworth BE, Haskell WL, Leon AS, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 71-80.
213. Enger SM, Ros RK, Paganini-Hill A, el al. Body size, physical activity and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomark Prev 2000; 9: 681-687.
214. Dirx MJ, Voorrips LE, Goldbohm RA, et al. Baseline recreational physical activity, history of sports participation, and postmenopausal breast carcinoma risk in the Netherlands Cohort Study. Cancer 2001; 92: 1638-1649.
215. Drake DA. A longitudinal study of physical activity and breast cancer prediction. Cancer Nurs 2001; 24: 371-377.
216. Moradi T, Adami HO, Erkborn A, et al. Physical activity and risk for breast cancer: a prospective cohort study among Swedish twins. Int J Cancer 2002; 100: 76-81.
217. Colditz GA, Feskanich D, Chen WY, et al. Physical activity and risk of breast cancer in premenopausal women. Br J Cancer 2003; 89: 847-851.
218. Shephard RJ, Shek PN. Cancer, inumme function, and physical activity. Can J Appl Physiol 1995; 20: 1-25.
219. Hoffman-Goetz; L, Apter D, Demark-Wahnefried W, et al. Possible mechanisms mediated an association between physical activity and breast cancer. Cancer 1998; 83: 621-628.
220. McTiernan A, Ulrich C, Slate S, et al. Physical activity and cancer etiology: association and mechanisms. Cancer Causes Control 1998; 9: 487-509.
221. Nieman DC, Pedersen BK. Exercise and immune function: recent developments. Sports Med 1999; 27: 73-80.
222. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001; 10: 15-32.
223. Kaaks R, Lukanova A. Energy balance and cancer: the role insulin-like growth factor-I. Proceedings of the Nutrition Society 2001; 60: 91-106.
224. Yu H. Role of the insulin - like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92: 1472-1488.
225. Sachdev D, Yee D. The IGF system and breast cancer. Endocr Relat Cancer 2001; 8: 197-209.
226. Rodgers AE. Selected recent studies of exercise, energy metabolism, body weight, and blood lipids relevant to interpretation and design of studies of exercise and cancer. Adv Exp Med Biol 1992; 322: 239-245.
227. Simoes EJ, Byers T, Coates RJ, et al. The association between leisure-time physical activity and dietary fat in American adults. Am J Public Health 1995; 85: 240-244.
228. Alfano CM, Klesges RC, Murray DM, et al History of sport participation in relation to obesity and related health behaviors in women. Prev Med 2002; 34: 82-89.
229. Jakicie JM, Mucus BH, Gallagher KI, et al Effect of exercise duration and intensity on weight loss in overweight, sedentary women. A randomized trial JAMA 2003; 290: 1323-1330.
230. Prentice RL, Pepe M, Self SG. Dietary fat and breast cancer: a quantitative assessment of the epidemiologic literature and an discussion of methodologic issues. Cancer Res 1989; 49: 3147-3156.
231. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993; 15: 110-132.
232. Willett WC. Diet and breast cancer. J Intern Med 2001; 249: 395-411.
233. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617-631.
234. Ziegler RG, Hoover RN, Hildeshein RN, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 1819-1827.
235. Rose DP. Diet, hormones, and cancer. Annu Rev Public Health 1993; 14: 1-17.
236. Lamartiniere CA. Timing of exposure and mammary cancer. J Mammary Gland Biology and Neoplasia 2002; 7: 67-76.
237. Howe GR, Hirohata T, Hislop TG, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Nalt Cancer Inst 1990; 82: 561-569.
238. LaVecchia C, Negri E, Franceschi S, et aL Olive oil, other dietary fats, and the risk of breast cancer (Italy). Cancer Causes Control 1995; 6: 545-550.
239. Stoll BA. Obesity, social class and western diet: a link to breast cancer prognosis. Eur J Cancer 1996; 32A: 1293-1295.
240. Mezetti M, La Vecchia C, Decarli A, et aL Population attributable risk for breast cancer diet, nutrition, and physical activity. J Natl Cancer Inst 1998; 90: 389-394.
241. Sitterri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45 (suppl. 1): 227-282.
242. Cleland WH, Mendelson CR, Simpson ER. Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol. Metab 1985; 60: 174-177.
243. Kimmick GG, Bell RA, Bostick RM. Vitamin E. and breast cancer: a review. Nutrition and Cancer 1997; 27: 109-117.
244. Taioli E, Barone J, Wynder EL. A case-control study of breast cancer and body mass. Eur J Cancer 1995; 31A: 723-728.
245. Calle EE, Rodriquez C, Walker-Thurmond K, el al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
246. Higginbotham S, Zhang ZF, Lee IM, et al. Dietary glycemic load and breast cancer risk in the Women's Health Study. Cancer Epidemiol Biomark Prev 2004; 13: 65-70.
247. Block G, Patterson B, Subar A. Fruit, vegetables and cancer prevention: a review of the epidemiologic evidence. Nutr Cancer 1992; 18: 1-29.
248. Ames BN, Gold LS. The causes and prevention of cancer: gaining perspective. Environ. Health Perspect 1997; 105 (suppl. 4): 865-873.
249. Bieri JG, Corash L, Hubbard VS. Medical uses of vitamin E. N Engl J Med 1983; 308: 1063-1071.
250. Hill SM, Bask DE. Effects of the pineal hormone melatonin an the proliferation and morphological characteristics of hunign breast cancer cells (MCF-7) in culture. Cancer Res 1988; 48: 6121-6126.
251. Paganini-Hill A, Chao A, Ross RK, et al. Vitamin A, β-carotene and the risk of breast cancer: a prospective study. J Natl Cancer Inst 1987; 79: 443-448.
252. Faff, J. Effects on the antioxidants supplementation in athletes on the exercise - induced oxidative stress. Biol Sport 2001; 18: 3-20.
253. Bartosz G. Druga twarz tlenu. Wolne rodniki w przyrodzie. Wydawnictwo Naukowe, PWN Warszawa 2003.
254. Wu AH, Wan P, Hankin J, et al. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002; 23: 1491-1496.
255. Yang CS, Chung JY, Yang G, et al. Tea and tea polyphenols in cancer prevention. J Nutr 2000; 130: 472S-478S.
256. Johnson KC, Hu J, Mao Y. Passive and active smoking and breast cancer risk in Canada, 1994-97, Cancer Causes Control 2000; 11: 211-221.
257. Marcus PM, Newman B, Millikan RC, et al. The association of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionising radiation with subsequent breast cancer risk (United States). Cancer Causes Control 2000; 11: 271-278.
258. Couch FJ, Cerhan JR, Vierkant RA, et al. Cigarette smoking increases risk for breast cancer in high - risk breast cancer families. Cancer Epidemiol Biomarkers Prev 2001; 10: 327-332.
259. Splangler JG, Michielutte R, Bell RA, et al. Association between smokeless tobacco use and breast cancer among Native-American women in North Carolina. Ethn Dis 2001; 11: 36-43.
260. Band PR, Le ND, Fang R, et al. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 2002; 360: 1044-1049.
261. Egan KM, Stampfer MJ, Hunter D, et al. Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology 2002; 13: 138-145.
262. Kropp S, Chan-Claude J. Active and passive smoking and risk of breast cancer by age 50 years among German women. Am J Epidemiol 2002; 156: 616-626.
263. Morabia A. Smoking (active and passive) and breast cancer: epidemiologic evidence up to June 2001. Environ Mol Mutagen 2002; 39: 89-95.
264. Collaborative Group on Hormonal Factors and Breast Cancer. Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 56,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002; 87: 1234-1245.
265. Maser E. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? TiPS 1997; 18: 270-275.
266. Rosenberg L, Metzger LS, Palmer JR. Alcohol consumption and risk of breast cancer: a review of the epidemiologic evidence. Epidemiol Rev 1993; 15: 133-144.
267. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286: 2143-2151.
268. Hamajima N, Hirose K, Tajima K, et al. Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002; 87: 1234-1245.
269. Dumeaux V, Alsaker E, Lund E. Breast cancer and specific types of oral contraceptives: a large Norvegian cohort study. Int J Cancer 2003; 105: 844-850.
270. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiologic studies. Lancet 1996; 347: 1713-1727.
271. Kenemans P, Bosman A. Breast cancer and postmenopausal hormone therapy. Breast Practice & Research Clinical Endocrinology & Metabolism 2003; 17: 123-137.
272. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results form the Women's Health Initiative randomised controlled trial. JAMA 2002; 288: 321-333.
273. Brinton LA Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev 1993; 15: 66-79.
274. Risch HA, Howe GR. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol 1994; 139: 670-683.
275. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-1593.
276. Beral V, Banks E, Appleby P. Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat 1999; 4:191-215.
277. Beral V, Banks E, Reeves G. Evidence from randomised trials on the-long term effects of hormone replacement therapy. Lancet 2002; 360: 942-944.
278. Banks E, Beral V, Bull D, et al. Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-427.
279. Gayet A, Estève J, Séradour B, et al. Does hormone replacement therapy increase the frequency of breast atypical hyperplasia in postmenopausal women? Results from the Bouche du Rhone district screening campaign. Eur J Cancer 2003; 39: 1738-1745.
280. Burkman RT, Tang MT, Malone KE, et al. Infertility drugs and the risk of breast cancer findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences study. Fertility and Sterility 2003; 74: 844-851.